COPD Initiative — Respiratory Health Association™ of Metropolitan Chicago

References

  • 2004 Surgeon General’s Report www.cdc.gov/tobacco/sgr/sgr_2004
  • American Society of Health-System Pharmacists. ASHP Therapeutic position statement on smoking cessation. Am J Health-Syst Pharm 1999; 56:460-4.
  • American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with Alpha-1 Antitrypsin Deficiency. Am J Respir Crit Care Med. 2003; 168:818-900.
  • American Thoracic Society. Standards for the diagnosis and care of patients with Chronic Obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77-S121.
  • American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152:1107-36.
  • Balzano G, Stefanelli F, Iorio C, de Felice A, Melillo EM, Martucci M, Melillo G. Eosinophilic Inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1486-92.
  • American Thoracic Society Website. ww.thoracic.org/COPD
  • Barnes PJ. Chronic Obstructive Pulmonary Disease. NEJM 2000; 343:269-79.
  • Bechtel, JJ, Kelley, WA, Coons, TA, Klein, MG, Slagel, DD, Petty, TL. (2005). Lung cancer detection in patients with airflow obstruction identified in a primary care outpatient practice. Chest, (127) 1140-5.
  • Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153(3):967-75.
  • Biskobing, DM. COPD and Osteoporosis. Chest 2002; 121:609-20.
  • Buist, A. Sonia, et al. “Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease.” Global Initiative for Chronic Obstructive Lung Disease, 2006, 49-56.
  • Boychuk JE, Malen JF. Lung transplantation. In: Smith SL (ed). Tissue and Organ Transplantation: Implications for Professional Nursing Practice. St. Louis, Mo: Mosby-Yearbook, Inc., 1990:260-272.
  • Chronic Obstructive Pulmonary Disease Surveillance – United States, 1971-2000. MMWR August 2, 2002; 51(SS-6):1-16.
  • Celli B. Pulmonary Rehabilitation for COPD. A practical approach for improving ventilatory conditioning. Postgraduate Medicine. 1998: Vol 103
  • “Chronic Obstructive Pulmonary Disease: Prevention.” copd.upmc.com/Prevention.htm l; August 10, 2005.
  • Chicago Department of Public Health, Publications and Newsletters, Community Area Inventories, 1992-2002. Chicago Health Profile, Table 5.5 – Lung cancer Mortality. Retrieved April 14, 2005 from egov.cityofchicago.org/webportal/COCWebPortal/COC_EDITORIAL/CAHIvol2.pdf
  • CIGNA HealthCare Coverage Position. Lung Volume Reduction Surgery. Coverage Position Number 0218. Original Effective Date 11/15/2004.
  • Clinical Coordinating Center For Lung Volume Reduction Surgery For Emphysema: A Multi-Center Assessment and Prospective Patient. NIH Guide, 25:17 May 24, 1996.
  • Cook County Department of Public Health, Vital Statistics, Community Profiles, Suburban Cook County. (2004). Retrieved April 21, 2005 from www.cookcountypublicheatlh.org/statistics/pdf/9901Profiles/Subcook.pdf
  • Cote C., Celli B. New Treatment Strategies for COPD. Pairing the new with the tried and true. Postgraduate Medicine 2005; Vol 117: No 3.
  • Croxton, TL, Weinmann, GG, Senior, RM, Wise, RA, Crapo, JD, Buist, AS (2003). Clinical Research in Chronic Obstructive Pulmonary Disease: Needs and Opportunities. NHLBI Workshop Summary. American Journal of Respiratory and Critical Care Medicine, (167) 1142-9.
  • Dahl, E. Mortality and life expectancy after hip fractures. Acta Ortho Scand 1980; 51:163-170.
  • Diane M. Biskobing. COPD and Osteoporosis. Chest 2002; 121:609- 20.
  • Dressendorfer RH, Haykowsky MJ, Eves, N. Exercise for persons with COPD. American College of Sports Medicine 2002.
  • “Diagnosis and Management of Chronic Obstructive Pulmonary Disease In the Primary Care Setting.” Special Report; August 2004.
  • Drug Information for the Healthcare Professional, USP DI 2003, 23rd edition, Micromedex Thompson Healthcare, 2003.
  • Drug Information for the Health Care Professional. USP DI, 27th edition. Micromedex Thomson Healthcare, 2007
  • Estimated annual prevalence of self-reported COPD, by sex and year – United States, National Health Interview Survey, 1960-2000.
  • Executive Summary: Global Strategy for the Diagnosis, Management, and Prevention of COPD 2005 Update.
  • Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville , MD: U.S. Department of Health and Human Services. Public Health Service. June 2000.
  • Fishman A, Martinez F, Naunheim K . A r andomized trial comparing lung- volume-reduction surgery with medical therapy for severe emphysema. N England J Med 2003 May 22; 348:2055-6. Epub 2003 May 20.
  • Fortunata Verdetti, Mark G. Graham. Chronic Obstructive Pulmonary Disease: Diagnosis and Treatment. Resident and Staff Physician. 2005:Vol. 51, No. 10:10-21
  • Garrity ER Jr, Villanueva J, Bhorade SM, Husain AN, Vigneswaran WT. Low rate of Acute lung allograft rejection after the use of daclizumab, an interleukin 2 Receptor antibody. Transplantation 2001; 71:773-7.
  • Global Initiative for Chronic Obstructive Lung Disease. Pocket Guide to COPD Diagnosis Management and Prevention. A Guide for Health Care Professionals. Updated July 2004.
  • Gorman JH III, Gorman RC, Kaiser L. Appropriate indications for single and bilateral lung transplantation. Current Opinion in Organ Transplantation 2001; 6:243-7.
  • Gotfried MH. Macrolides for the treatment of chronic Sinusitis, Asthma, and COPD. Chest.2004: 125:52-61.
  • Hillerdal G, Skoogh BE, Forslund-Stiby D, et al. Comparison of Lung Volume Reduction Surgery and Physical Training on Health Status and Physiologic Outcomes. Chest 2005; 128:3489-99.
  • Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. The Lancet 2004; 364: 709-21.
  • Illinois Hospital Association (2005). COMPdata®. Accessed April 18, 2006 from www.compdatainfo.com/news/monitor/illinois/lungrep.pdf
  • Ions, GK & Stevens, J. Prediction of survival in patients with femoral neck fracture. J Bone Joint Surg 1987; 69B:384-7.
  • Jeffery P.K. Lymphocytes, Chronic bronchitis and chronic obstructive pulmonary disease. In: Chadwick D and Goode JA, editors. Chronic obstructive pulmonary disease: pathogenesis to treatment. Novartis Foundation symposium 234. New York: John Wiley & Sons; 2001, p. 149-161.
  • Jensen SP, Lynch DA, Brown KK, et al. High-resolution CT features of severe asthma and bronchiolitis obliterans. Clin Radiol 2002; 57:1078-1085.
  • Lee-Chiong Jr TL , Matthay RA . Pulmonary Hypertension and cor pulmonale in COPD. Semin Respir Crit Care Med 2003; 24:263-72.
  • Loganathan, RS, Stover, DE, Weiji, S, Venkatranman, E. (2006). Prevalence of COPD in Women Compared to men around the time of diagnosis of primary lung cancer. Chest, (129) 1305-12.
  • Lung Cancer Alliance. 2005 Report Card on Lung Cancer. Accessed March 14, 2006 from www.lungcanceralliance.org/involved/reportcard.html
  • Lynch DA, Newell JD, Tschomper BA, et al. Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology 1993; 188:829-833.
  • Magaziner J, Hawkes W, Hebel JR, Zimerman SI, Fox KM, Dolan M, et al. Recovery from hip fracture in eight areas of function. Journal of Gerontology: Medical Sciences 2000; 55A:M498-507.
  • Mahler DA, Huang S, Tabrizi M, Bell GM. Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study. Chest. 2004: 126:926-934.
  • Mao JT, Tashkin DP, Belloni PN, et al. All-trans retinoic acid modulates the brhance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest. 2003; 124:1724-1732.
  • Mason, RJ, Murray, JF, Broadus VC, Nadel JA. Chronic Obstructive Pulmonary Disease. Murray and Nadels Textbook of Respiratory Medicine. 4 th edition. Chapter 25, p. 751-759
  • McDonald CF. Shortness of breath. Is it chronic obstructive pulmonary disease? Aust Fam Physician 2005; 34:541-5.
  • Meyer BF, Sundaresan RS, Cooper JD, Patterson GA. Bilateral sequential lung transplant without sternal division eliminates post transplant sternal complications. J Thorac Cardiovasc Surg 1999; 117:358-364.
  • Miller JD, Malthaner RA, Goldsmith CA, et al. Lung Volume Reduction Surgery vs. Medical Treatment. Chest 2005; 127:1166-77.
  • Mitsunobu F, Mifune T, Ashida K, et al. Low-attenuation areas of the lungs on high resolution Computed tomography in asthma. J Asthma 2001; 38:413-422.
  • Nairn R, Helbert M. Immunology for medical students. New York: Mosby 2002. p. 3-107.
  • Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of Airway dimensions and emphysema in smokers: correlation with Lung Function. Am J Respir Crit Care Med 2000; 162:1102-1108.
  • Nathan S, Edwards L, Barnett SD , et al. Outcomes of COPD Lung Transplant Recipients After Lung Volume Reduction Surgery. Chest 2004; 126:1569-1574.
  • National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. 1997 National Institutes of Health. Bethesda MD: NIH Publication No. 97–4051
  • National Cancer Institute U.S. National Institutes of Health (2005) Fact Sheet: Secondhand Smoke: Questions and Answers. Accessed November 14, 2005 from www.cancer.gov/cancertopics/factsheet/Tobacco/cancer
  • National Center for Chronic Disease Prevention and Health Promotion (2004). Cancer Prevention and Control: Lung Cancer Statistics. Retrieved April 14, 2005 from www.cdc.gov/cancer/lung/statistics.htm
  • National Emphysema Treatment Trial. (NETT): Evaluation of Lung Volume Reduction Surgery For Emphysema. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute. www.nhlbi.nih.gov/health/prof/lung/nett/lvrsweb.htm.
  • National Lung Health Education Program. Frontline Treatment of COPD. Treatment Complications of Sleep Disorders. Copyright © The Snowdrift Pulmonary Foundation, Inc. 2000 www.nlhep.org/books/TrtmntCOPD/16_treatment_complications_H3.html.
  • Palm KH, Decker WW. Acute Exacerbations of chronic obstructive pulmonary disease. Emerg Med Clin N Am 2003; 21:331-352.
  • Pan Z-Z, Parkyn L, Ray A, Ray P. Inducible lung-specific expression of RANTES: preferential recruitment of neutrophils. Am J Physiol Lung Cell Mol Physiol 2000; 279:L658-L66.
  • Patel, JD, Bach, PB, Kris, MG (2004). Lung cancer in women: A contemporary Epidemic. Journal of the American Medical Association, 291(4):1763-1768
  • Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001; 163:1256-76.
  • Peters MJ, Morgan LC. The pharmacotherapy of smoking cessation. Med J Aust 2002; 176:486-90.
  • Petty TL. The rising epidemic of COPD in women: Why women are more susceptible; how treatment should differ.
  • Popovic JR. 1999 National Hospital Discharge Survey: Annual summary with detailed diagnosis and procedure data. National Center for Health Statistics. Vital Health Statistics 2001; 13:23,154.
  • Pulmonary Rehabilitation – 1999. American Thoracic Society. Am J Respir Crit Care Med 1999: 159 (5Pt 1):1666-82
  • Ramirez J, Patterson GA. Airway complications after lung transplantation. Semin Thorac Cardiovasc Surg 1992; 4:147-153.
  • Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, Colditz GA, Speizer FE, Barr RG, Camargo CA Jr. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004; 27:2478-84.
  • “Respiratory Disease” www.umm.edu/respiratory/chrnbron.htm. Jun 22, 2005
  • Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK (eds). SEER Cancer Statistics Review, 1975- 2001, National Cancer Institute. Bethesda, MD, seer.cancer.gov/csr/1975_2001, 2004.
  • Sharma S, Unruh H. Lung Transplantation. Emedicine.com, Inc. 2004 www.emedicine.com/med/topic2980.htm#section~author_information
  • Silkoff P, Zhang L, Dutton S, Langmack E, Vedal S, Murphy J, Make B. Winter pollution and disease parameters in advanced chronic obstructive pulmonary disease panels residing in Denver, Colorado. J Allergy Clin Immunol 2005; 337-344.
  • Silva GE, Sherrill DL, Guerra S and Barbee RA. Asthma as a Risk Factor for COPD in a Longitudinal Study. Chest 2004; 126:59-65.
  • Smart B. When Asthma and COPD Coexist. American Academy of Allergy Asthma and Immunology. 1996-2006.
  • Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128:2099-107.
  • “Standards for the Diagnosis and Management of Patients with COPD.” The American Thoracic Society, 2006, 61-74.
  • Sunday SR, Folan P. Smoking in adolescence: what a clinician can do to help. Med Clin North Am 2004 Nov; 88:1495-515.
  • Surgical Procedures for Lung Transplantation. Organ Transplant 2002 – 2002 Medscape.
  • Surgical Treatment for Emphysema. Cheshire Medical Center or Dartmouth-Hitchcock Medical Center: www.cheshire-med.com/programs/pulrehab/lvrs.html
  • Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153:1802-11.
  • Tietze KJ. Disorders related to cold and allergy. Berardi RR, McDermott JH, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs. 14th edition. Washington DC: APhA 2004. p 239-70.
  • Torres JP, Casanova C, Hernandez C, Abreau J, Aguirre-Jame A, Celli BR. Gender and COPD in patients attending a pulmonary clinic. Chest 2005; 128:2012-6.
  • Truwit J. Pulmonary disorders and exercise. Clin Sports Med 2003; 22:161-180.
  • United States Department of Health and Human Services. National Institute of Health. National Heart, Lung and Blood Institute. Diseases and Conditions Index. www.nhlbi.nih.gov/health/dci/Diseases/Copd/Copd_Treatments.html
  • University of Maryland Medical Center. Thoracic Surgery Division. Lung Volume Reduction Surgery: www.umm.edu/thoracic/lvrs1.html
  • University of Massachusetts. Worcester Campus Pulmonary, Allergy & Critical Care Medicine. 55 Lake Avenue North Worcester, MA 01605.
  • Urbano, Fl, Pascual RM. “Contemporary Issues in the Care of Patients with Chronic Obstructive Pulmonary Disorder.” J Manag Care Pharm 2005; 11: 2-13.
  • U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999 – 2002 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2005. Accessed 12.5.05 from www.cdc.gov/cancer/npcr/uscs
  • Vineis, P, Airoldi, L, Veglia, F, et al (2005) Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. British Medical Journal, BMJ, doi:10.11136/bmj.38327.648472.82 (published 28 January 2005)
  • Wedzicha JA, Seemungal TA, MacCallum PK , et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000; 84:210-5.
  • Weill D, Keshavjee S. Lung transplantation for emphysema: two lungs or one. J Heart Lung Transplant 2001; 20:739-742.
  • www.umassmed.edu/pulmonary/lungred.cfm.
  • Weiss ST, Demeo DC, Postma DS, COPD: Problems in Diagnosis and measurement. Eur Respir J 2003; 21:4S-12S.
  • White BL, Fisher WD, Laurin CA: Rate of mortality for elderly patients after fracture of the hip in the 1980’s. J Bone J Surg 1987; 69A:1335-40.
  • Wilken, Lori. PharmD, CDE, AE-C. “Chronic Obstructive Pulmonary Disease.” UIC College of Pharmacy, PHAR 404. Feb 16 and Feb 21, 2006
  • W. MacNee, A. Agusti, J.C. Hogg, R. Rodriguez-Roisin. Pathology, pathogenesis and pathophysiology. American Thoracic Society and European Respiratory Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. 2004:24-37.
  • Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute respiratory illness in patients with COPD and the effectiveness of Influenza vaccination: a randomized controlled study. Chest. 2004: 125:2011-2020
  • www.amplivox.ltd.uk/microlab.html; August 21, 2005.
  • Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr, Chapman HA Jr, Shapiro SD, Elias JA. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000; 106:1081-93.
 

Back to Top